CONMED CORPORATION Option Indexed to Issuer's Equity, Strike Price
CONMED CORPORATION (CNMD) reported Option Indexed to Issuer's Equity, Strike Price of $114.92 per share for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-04-26.
Discontinued › Notes › Other Liabilities
us-gaap:OptionIndexedToIssuersEquityStrikePrice1 · last filed 2019-04-26
- CONMED CORPORATION option indexed to issuer's equity, strike price for the quarter ending 2019-03-31 was $114.92.
| Period end | Option Indexed to Issuer's Equity, Strike Price 3 month |
|---|---|
| 2019-03-31 | $114.92 10-Q · filed 2019-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |